Global Gaucher Disease Treatment Market Value Will Reach $1.16 Billion by 2024; Finds New Report
Sales of Gaucher disease therapeutics will rise gradually from $875 million in 2014 to $1.16 billion by 2024 across the seven major markets (7MM) of the UK, Italy, Spain, France, Germany, the US and Israel, at a Compound Annual Growth Rate (CAGR) of 2.9%, according to new research.
View full press release